Maternal COVID-19 Vaccine May Reduce the Risk of MIS-C in Infants: A Narrative Review
COVID-19 infection in the pediatric population usually leads to a mild illness; however, a rare but serious complication of MIS-C has been seen in children. MIS-C usually presents 2–4 weeks after COVID-19 infection or exposure, and rare reports have been documented in neonates. Vaccinations for COVI...
Main Authors: | Chetna Mangat, Siva Naga Srinivas Yarrarapu, Gagandeep Singh, Pankaj Bansal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/9/1454 |
Similar Items
-
Multisystem inflammatory syndrome in children (MIS-C) secondary to COVID-19 mRNA vaccination – A case report from Qatar
by: Manoj Varghese, et al.
Published: (2022-01-01) -
The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs
by: Flor M. Munoz, et al.
Published: (2018-12-01) -
Vaccination information fathers receive during pregnancy and determinants of infant vaccination timeliness
by: Catherine A. Gilchrist, et al.
Published: (2021-12-01) -
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis
by: Mohamad Hamad Saied, et al.
Published: (2023-08-01) -
Maternal vaccination: A narrative review
by: Sahra Ashkir, et al.
Published: (2022-09-01)